Cargando…
Emerging therapies for hemophilia: controversies and unanswered questions
Several new therapies for hemophilia have emerged in recent years. These strategies range from extended half-life factor replacement products and non-factor options with improved pharmacokinetic profiles to gene therapy aiming for phenotypic cure. While these products have the potential to change he...
Autores principales: | Arruda, Valder R., Doshi, Bhavya S., Samelson-Jones, Benjamin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931262/ https://www.ncbi.nlm.nih.gov/pubmed/29770199 http://dx.doi.org/10.12688/f1000research.12491.1 |
Ejemplares similares
-
Gene Therapy for Hemophilia: Facts and Quandaries in the 21st Century
por: Arruda, Valder R., et al.
Publicado: (2020) -
Protein-Engineered Coagulation Factors for Hemophilia Gene Therapy
por: Samelson-Jones, Benjamin J., et al.
Publicado: (2018) -
Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia A
por: Samelson-Jones, Benjamin J., et al.
Publicado: (2020) -
Polyp Resection - Controversial Practices and Unanswered Questions
por: von Renteln, Daniel, et al.
Publicado: (2017) -
Aquaporin water channels: unanswered questions and unresolved controversies
por: Agre, Peter, et al.
Publicado: (1995)